Announced Fri, 14 Aug, 2026 · 15:34 IST
Q1 FY27 results: Johnson Pharmacare posts Rs 110 lakh loss on nil revenue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹0.47
prior close
₹0.47
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-2.1+0.0+0.0+0.0-2.1+0.0+0.0+0.0-2.1-2.1+0.0——
Up moveDown movePending
AI summary
Johnson Pharmacare reported unaudited Q1 FY27 results showing nil revenue from operations and a net loss of Rs 110.31 lakh, widening sharply from Rs 5.34 lakh loss in the same quarter last year. Loss per share stood at Rs 0.02. Paid up equity share capital remained Rs 5,500 lakh. The results were approved at the board meeting on August 13, 2026. This filing is a routine newspaper publication of those already-filed quarterly results under SEBI LODR Regulation 47.
Likely market impact
Continued zero revenue and wider losses flag ongoing operational stress; no near term positive catalyst visible for shareholders.